Accord Healthcare
Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to more than 70 countries globally.
ADVERSE DRUG
REACTION
REPORT
Falsified Medicines Directive
Click Here
GROWTH’S IN OUR NATURE
Accord Healthcare is one of the fastest growing generic pharmaceutical companies in the UK & Ireland.
Acquiring Actavis UK and Ireland in 2017 facilitates Accord’s ambition to become a top 5 pan-EMENA generics company by 2021 and have developed a specialty products commercialisation capability.
TRULY MULTINATIONAL
Accord has one of the most extensive sales, marketing and distribution networks in Europe. Headquartered from UK, Accord now supplies products to close to 65 EMENA markets.
A COMPLETE APPROACH
Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.
EUROPEAN FOCUS
Accord currently has a portfolio comprising nearly 7000 product approvals in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.
News
Accord-UK exhibit at the British Society for Rheumatology Conference 2019
Accord-UK were pleased to exhibit at the British Society for Rheumatology Conference this week.
This annual conference is the foremost event within the rheumatology field and is attended...
Celebrating ‘National Apprenticeship Week 2019’
This week is the 12th Annual National Apprenticeship Week (4th-8th March) and we are celebrating our apprentices and how apprenticeships make a difference to Accord Healthcare. We...